{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:42:57Z","timestamp":1789684977597,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.03.027","type":"journal-article","created":{"date-parts":[[2009,4,5]],"date-time":"2009-04-05T03:34:36Z","timestamp":1238902476000},"page":"4350-4354","source":"Crossref","is-referenced-by-count":19,"title":["Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"27","author":[{"given":"Siriwan","family":"Sirikwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirirat","family":"Likanonsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"SimakanWaradejwinyoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirima","family":"Pattamadilok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanit","family":"Kumperasart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achara","family":"Chaovavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathaporn","family":"Manatsathit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Malerczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantapong","family":"Wasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.03.027_bib1","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"14","key":"10.1016\/j.vaccine.2009.03.027_bib2","first-page":"109","article-title":"Rabies vaccines","volume":"77","author":"WHO","year":"2002","journal-title":"Week Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2009.03.027_bib3","first-page":"120","article-title":"Rabies and dog population control in Thailand: success or failure?","volume":"88","author":"Hemachudha","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2009.03.027_bib4","unstructured":"Bureau of Epidemiology, Department of Disease Control. Annual epidemiological surveillance report. Nonthaburi: Ministry of Public Health; 1997\u20132006 [in Thai]."},{"key":"10.1016\/j.vaccine.2009.03.027_bib5","unstructured":"WHO. WHO Expert Consultation on Rabies. WHO Tech Rep Ser 931. Geneva: World Health Organization; 2004."},{"key":"10.1016\/j.vaccine.2009.03.027_bib6","unstructured":"WHO. Intradermal application of rabies vaccines. Report of a WHO Consultation, Communicable Disease Surveillance and Control. WHO\/CDS\/CSR\/APH\/2000.5, Bangkok, Thailand; 2000."},{"key":"10.1016\/j.vaccine.2009.03.027_bib7","unstructured":"Bureau of Epidemiology, Dept. of Disease Control, Ministry of Public Health, Thailand. Annual epidemiological surveillance report, <http:\/\/203.157.15.4\/Annual\/Annual49\/Part2\/Age_Group\/Age_42_Rabies%20.html>; 2006 [accessed 15.09.08]."},{"issue":"8382","key":"10.1016\/j.vaccine.2009.03.027_bib8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(84)91340-0","article-title":"Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens","volume":"1","author":"Warrell","year":"1984","journal-title":"Lancet"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.03.027_bib9","first-page":"439","article-title":"Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man","volume":"265","author":"Scheiermann","year":"1987","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.027_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2\u20131\u20131 postexposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.027_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0264-410X(87)90102-2","article-title":"Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man","volume":"5","author":"Nicholson","year":"1987","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.027_bib12","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.03.027_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1201-9712(02)90113-X","article-title":"Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals","volume":"6","author":"Madhusudana","year":"2002","journal-title":"Int J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2009.03.027_bib14","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0,1mL PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.027_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.03.027_bib16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0264-410X(00)00322-4","article-title":"Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination","volume":"19","author":"Thisyakorn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.03.027_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/517241","article-title":"Post-exposure Rabies vaccination in patients infected with Human Immunodeficiency Virus","volume":"28","author":"Jaijaroensup","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.027_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/003655401750174183","article-title":"Failure of pre- and postexposure rabies vaccination in a child infected with HIV","volume":"33","author":"Pancharoen","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2009.03.027_bib19","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.027_bib20","first-page":"99","article-title":"Post-exposure rabies prophylaxis in HIV infected patients","volume":"29","author":"Sirikwin","year":"2003","journal-title":"Dis Control J"},{"key":"10.1016\/j.vaccine.2009.03.027_bib21","first-page":"354","article-title":"A rapid tissue culture test for determining rabies neutralizing antibody","volume":"23","author":"Smith","year":"1973","journal-title":"WHO Monogr Ser"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.027_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/313610","article-title":"Safety and immunogenicity of pre-exposure rabies vaccination in children infected with human immunodeficiency virus type 1","volume":"30","author":"Thisyakorn","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.027_bib23","first-page":"1054","article-title":"Change in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients","volume":"11","author":"Donovan","year":"1997","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.027_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Exp Rev Vac"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.027_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid1301.060810","article-title":"Rabies encephalitis in malaria-endemic area, Malawi, Africa","volume":"13","author":"Mallewa","year":"2007","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T12:25:33Z","timestamp":1545308733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09004332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09004332"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}